Vaginal adenosis
Vaginal adenosis is a rare, benign (non-cancerous) condition in which the lining of the vagina is composed of glandular cells, rather than the usual squamous cells. These glandular cells are similar to those found in the lining of the uterus. This condition is most commonly seen in women who were exposed to the drug diethylstilbestrol (DES) in utero, but it can also occur spontaneously.
Causes[edit]
The primary cause of vaginal adenosis is exposure to DES in utero. DES is a synthetic form of estrogen that was prescribed to pregnant women from the 1940s to the 1970s to prevent miscarriage. However, it was later discovered that this drug can cause a variety of health problems in the daughters of women who took it, including vaginal adenosis.
Symptoms[edit]
Many women with vaginal adenosis do not experience any symptoms. However, some may experience vaginal bleeding or discharge, or have visible red patches on the vaginal walls. In some cases, vaginal adenosis can lead to an increased risk of developing vaginal cancer.
Diagnosis[edit]
Vaginal adenosis is typically diagnosed through a pelvic examination and a biopsy of the vaginal tissue. The biopsy can confirm the presence of glandular cells in the vaginal lining.
Treatment[edit]
Treatment for vaginal adenosis is typically not necessary unless the condition is causing symptoms. In cases where treatment is needed, options may include surgery to remove the affected tissue, laser therapy, or cryotherapy (freezing the abnormal cells).
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
